BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, December 17, 2025
Home » targets

Articles Tagged with ''targets''

Cancer cells under magnifying glass
Cancer

DAXX promotes tumorigenesis through de novo lipogenesis, study reveals

April 13, 2023
Tumor cells are known to produce high amounts of intracellular lipids, leading to increased levels of fatty acids, cholesterol and membrane phospholipids. Death domain-associated protein (DAXX) is a small ubiquitin-related modifier (SUMO)-binding protein that plays a role in transcription regulation by interacting with transcription factors such as p53 and NF-κB.
Read More
Brain and blood cells
Neurology/Psychiatric

Targeting plasma ASM protects against several neuropathological features in AD mice

April 13, 2023
Acid sphingomyelinase (ASM) is a sphingolipid metabolizing enzyme that catalyzes the hydrolysis of sphingomyelin to ceramide. Previous studies revealed high activity of ASM in the blood and brain of old vs. young individuals or mice, and they implicated this enzyme in neurodegenerative disease pathology.
Read More
Colorized cells.
Cancer

PIP4K2B emerges as a potential target for cancer therapy

April 12, 2023
Researchers at The AIRC Institute of Molecular Oncology in Milan have discovered that the targetable enzyme phosphatidylinositol 5-phosphate 4-kinase type-2 β (PIP4K2B) participates in mechanosensing leading to changes in gene expression, nuclear morphology and cellular motility. The expression of PIP4K2B bodes a poor prognosis in cancer patients and PIP4K2B is the sole PIP4K isoform localized to the nucleus.
Read More
Nephrology

NEU1 expressed by tubular epithelial cells plays a role in renal injury and renal fibrosis in vivo

April 12, 2023
A recent study investigated the role of neuraminidase 1 (NEU1) in renal fibrosis. Researchers found increased levels of NEU1 in the fibrotic kidneys of patients and two mouse models of renal fibrosis (mice subjected to unilateral ureteral obstruction or administered folic acid).
Read More
Colorectal cancer illustration
Cancer

CLEC7A blockade protects against colorectal tumorigenesis in mice

April 12, 2023
C-type lectin receptor is a family of molecules consisting of several proteins that recognize a broad spectrum of ligands, such as immunoreceptor tyrosine-based activation motif (ITAM) and immunoreceptor tyrosine-based inhibitory motif (ITIM), and are known to regulate diverse immunological functions.
Read More
Immuno-oncology

First-in-class selective covalent SHP-1 inhibitor disclosed

April 11, 2023
Protein-tyrosine phosphatase SHP-1 is a negative regulator of immune cell function and is broadly expressed in the hematopoietic compartment. Due to its role in immune cell signaling, SHP-1 may be explored as a target for tumor immunotherapy.
Read More
Kidneys
Nephrology

PTP4A1 knockout ameliorates renal injury in murine model

April 5, 2023
Protein tyrosine phosphatase 4A1 (PTP4A1) is known to promote tumor growth and migration of tumoral cells, but its role in the kidney has not been deeply explored. Researchers from Korea have aimed to investigate the role of PTP4A1 during kidney fibrosis and suggest it as a potential therapeutic target.
Read More
Neurology/Psychiatric

S100A9 identified as a therapeutic target in paclitaxel-induced peripheral neuropathy

March 24, 2023
When tissue injury occurs, stressed cells release a bunch of intracellular molecules called damage-associated molecular pattern (DAMP) proteins. S100 calcium binding protein A9 (S100A9) is a DAMP usually found in macrophages and is involved in multiple inflammatory responses, such as activation of Toll-like receptor 4 (TLR4).
Read More
Endocrine/Metabolic

Targeting GPR10 as therapeutic strategy for obesity

March 24, 2023
It has been previously demonstrated that disruption of brain-expressed G protein-coupled receptor-10 (GPR10) causes obesity in animals...
Read More
Cancer

KK-CL-1 identified as new therapeutic target in triple-negative breast cancer

March 23, 2023
Kita-Kyushu lung cancer antigen-1 (KK-LC-1) is a member of the cancer/testis antigens (CTAs) protein family, which is family of proteins that are mainly expressed in tumors and testicular tissue, but they display low to no expression in other normal tissues.
Read More
Previous 1 2 … 39 40 41 42 43 44 45 46 47 … 51 52 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 17, 2025.
  • IPO puzzle pieces

    Medline raises $6.3B in fourth med-tech IPO of December

    BioWorld MedTech
    Medline Inc. returned to the public markets with a blockbuster IPO of $6.26 billion, reportedly this year’s largest IPO globally. The upsized offering of more...
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 17, 2025.
  • Child pushing away bowl of peanuts

    Vitesse finesse pays off: DBV wins in peanut allergy phase III

    BioWorld

    DBV Technologies SA’s pivotal phase III trial with the Viaskin Peanut allergy patch came through for the company, and officials plan a BLA filing with the U.S....

  • IPO stock market ticker

    Acryl raises $28M IPO, aiming to bridge medical divide with AI

    BioWorld MedTech
    Acryl Inc. debuted on South Korea’s Kosdaq Dec. 16, raising ₩42.12 billion ($28.5 million) in an IPO. Shares (KOSDAQ:0007C0) closed at ₩67,000 on the first day,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing